Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.43B |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$805M |
| 3 |
Meta Platforms (Facebook)
META
|
+$713M |
| 4 |
Amazon
AMZN
|
+$688M |
| 5 |
Tesla
TSLA
|
+$525M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.96B |
| 2 |
Spotify
SPOT
|
+$1.22B |
| 3 |
Microsoft
MSFT
|
+$847M |
| 4 |
Apollo Global Management
APO
|
+$757M |
| 5 |
Workday
WDAY
|
+$444M |
Sector Composition
| 1 | Technology | 15.78% |
| 2 | Financials | 14.57% |
| 3 | Healthcare | 12.51% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Kezar Life Sciences
KZR
$28.9M
| $291K | ﹤0.01% |
43,337
-6,086
| -12% | -$40.9K |
|
3402
Horace Mann Educators
HMN
$1.93B
| $291K | ﹤0.01% |
7,417
-21,771
| -75% | -$854K |
|
3403
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.35B
| $291K | ﹤0.01% |
10,746
-1,583
| -13% | -$42.8K |
|
3404
Vor Biopharma
VOR
$228M
| $291K | ﹤0.01% |
261,837
-41,988
| -14% | -$46.6K |
|
3405
Applied Optoelectronics
AAOI
$1.68B
| $290K | ﹤0.01% |
7,875
-600,276
| -99% | -$22.1M |
|
3406
Titan International
TWI
$550M
| $290K | ﹤0.01% |
42,723
-41,122
| -49% | -$279K |
|
3407
Peoples Bancorp
PEBO
$1.08B
| $290K | ﹤0.01% |
9,138
-73,214
| -89% | -$2.32M |
|
|
PEO
3408
Adams Natural Resources Fund
PEO
$582M
| $289K | ﹤0.01% |
13,310
-14,839
| -53% | -$323K |
|
3409
BuzzFeed
BZFD
$75.6M
| $289K | ﹤0.01% |
+108,348
| New | +$289K |
|
3410
AN2 Therapeutics
ANTX
$34.2M
| $289K | ﹤0.01% |
209,366
-188,559
| -47% | -$260K |
|
|
GMRE
3411
Global Medical REIT
GMRE
$512M
| $289K | ﹤0.01% |
37,397
-124,630
| -77% | -$962K |
|
3412
Lincoln Educational Services
LINC
$627M
| $288K | ﹤0.01% |
+18,183
| New | +$288K |
|
3413
UBS Group
UBS
$128B
| $287K | ﹤0.01% |
+9,480
| New | +$287K |
|
3414
First Trust Exchange-Traded Fund VIII First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.39B
| $285K | ﹤0.01% |
+6,641
| New | +$285K |
|
3415
Ohio Valley Banc Corp
OVBC
$175M
| $285K | ﹤0.01% |
11,772
-1,486
| -11% | -$36K |
|
3416
Clarus
CLAR
$149M
| $285K | ﹤0.01% |
63,113
-179,903
| -74% | -$811K |
|
3417
Organon & Co
OGN
$2.75B
| $282K | ﹤0.01% |
18,916
-72,717
| -79% | -$1.08M |
|
3418
Playboy, Inc. Common Stock
PLBY
$175M
| $281K | ﹤0.01% |
+192,145
| New | +$281K |
|
3419
Farmers National Banc Corp
FMNB
$555M
| $279K | ﹤0.01% |
19,624
-54,461
| -74% | -$774K |
|
|
ETX
3420
Eaton Vance Municipal Income 2028 Term Trust
ETX
$207M
| $279K | ﹤0.01% |
15,845
| – | – |
|
3421
Elbit Systems
ESLT
$23.3B
| $278K | ﹤0.01% |
1,078
-36,676
| -97% | -$9.46M |
|
3422
Y-mAbs Therapeutics
YMAB
$391M
| $278K | ﹤0.01% |
35,447
-36,139
| -50% | -$283K |
|
3423
Rogers Corp
ROG
$1.48B
| $276K | ﹤0.01% |
2,720
-11,794
| -81% | -$1.2M |
|
3424
AMES National
ATLO
$183M
| $276K | ﹤0.01% |
+16,782
| New | +$276K |
|
3425
Northwest Natural Holdings
NWN
$1.73B
| $275K | ﹤0.01% |
6,962
-33,020
| -83% | -$1.31M |
|